{"transactions":[{"id":2791257,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-12T21:53:02.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in equal monthly installments for forty-eight months beginning on April 1, 2021, with the first installment vesting on May 1, 2021 subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":3.5,"expiration_date":"2031-03-10","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0000899243-21-011336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924321011336/doc4.xml","form_type":"4"}},{"id":2791256,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-12T21:53:02.000Z","date":"2021-03-10","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock were granted on March 10, 2021, and will vest beginning on April 1, 2021 (the \"Vesting Start Date\") in four equal annual installments on each anniversary of the Vesting Start Date, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0000899243-21-011336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924321011336/doc4.xml","form_type":"4"}},{"id":3212965,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-12T22:00:32.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest and become exercisable in equal monthly installments for forty-eight months beginning on April 10, 2020, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date."}],"balance_after":54000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0000899243-20-008100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924320008100/doc4.xml","form_type":"4"}},{"id":3212964,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-03-12T22:00:32.000Z","date":"2020-03-10","kind":"grant","acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of restricted stock were granted on March 10, 2020 (the \"Grant Date\") and will vest in four equal annual installments on each anniversary of the Grant Date, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date."}],"balance_after":21500,"source":{"system":"sec-edgar","filing":"0000899243-20-008100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924320008100/doc4.xml","form_type":"4"}},{"id":3326653,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-02T13:00:30.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest and become exercisable as to one-fourth (1/4) of the shares on September 16, 2020, and the remainder will vest and become exercisable at one-forty-eighth (1/48th) of the shares per month thereafter, subject to the Reporting Person continuing to provide services to the Issuer as Chief Medical Officer through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":2.58,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-20-000021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924320000021/doc4.xml","form_type":"4"}},{"id":3406181,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":141410,"kind":"person","name":"Riese Richard J.","position":1,"cik":"0001786692","reported_name":"Riese Richard J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-09-25T20:30:37.000Z","date":"2019-09-23","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 23, 2019 (the \"Grant Date\"), the reporting person was granted 8,000 shares of restricted stock of the company under the company's 2015 Equity Incentive Award Plan as part of a company-wide equity grant that was made to all employees. 100% of the shares of restricted stock will vest 18 months from the Grant Date."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0000899243-19-024249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527599/000089924319024249/doc4.xml","form_type":"4"}}]}